Epworth HealthCare is a provider of acute medical, surgical and rehabilitation services in Melbourne, Australia.

During the past decade, Epworth HealthCare conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 8 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epworth HealthCare" #1 sponsor was "Pfizer" with 4 trials, followed by "Bayer" with 2 trials sponsored, "Medtronic Cardiovascular" with 2 trials sponsored, "University of Sydney" with 2 trials sponsored and "Achieve Life Sciences" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epworth HealthCare" #1 collaborator was "Ambrx, Inc." with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Canadian Critical Care Trials Group" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Epworth HealthCare" are "Bladder Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Leukemia" (2 trials), "Lymphoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Epworth HealthCare" in a lesser frequency.

Most popular intervention types in "Epworth HealthCare" are "Drug" (31 trials), "Biological" (6 trials), "Device" (6 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cisplatin" (3 trials), "Anetumab ravtansine (BAY94-9343)" (2 trials), "Carboplatin" (2 trials) and "Nab paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Epworth HealthCare" are 37 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Epworth HealthCare". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Epworth HealthCare, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Epworth HealthCare, 16 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".